Sigyn Therapeutics (SIGY) Return on Sales (2017 - 2020)
Sigyn Therapeutics (SIGY) posted Return on Sales of 0.77% for Q3 2020, down 476.39% sequentially from 0.13% in Q2 2020, and down 79.0% YoY from 3.68% in Q4 2019.
Sigyn Therapeutics (SIGY) Return on Sales (2017 - 2020) Analysis & Trends
Sigyn Therapeutics has reported Return on Sales for 4 years, with the latest figure at 0.77% in Q3 2020.
- Quarterly Return on Sales fell 79.0% year-over-year to 0.77% in Q3 2020, while the trailing twelve-month figure through Sep 2020 was 0.81% (down 83.0% YoY) and the FY2019 annual result came in at 0.02%, up 13.0% from the prior year.
- Return on Sales retreated to 0.77% in Q3 2020 per SIGY's latest filing, from 0.13% in the prior quarter.
- Over five years, Return on Sales peaked at 53.1% in Q4 2018 and troughed at 3.32% in Q1 2020.
- A 4-year average of 3.24% and a median of 0.02% in 2017 frame the typical range for Return on Sales.
- The sharpest annual moves came in 2018 and 2019: Return on Sales surged 5309 bps in 2018, then plunged 5308 bps in 2019.
- Over 4 years, Return on Sales stood at 0.01% in 2017, then surged by 637022 bps to 53.1% in 2018, then sank by 100 bps to 0.02% in 2019, then slumped by 4743 bps to 0.77% in 2020.
- According to Business Quant data, Return on Sales over the past three periods registered 0.77%, 0.13%, and 3.32% for Q3 2020, Q2 2020, and Q1 2020 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.00% |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -0.77% |
| Jun 30, 2020 | -0.13% |
| Mar 31, 2020 | -3.32% |
| Dec 31, 2019 | 0.02% |
| Sep 30, 2019 | 0.02% |
| Jun 30, 2019 | 0.01% |
| Mar 31, 2019 | 0.06% |
| Dec 31, 2018 | 53.10% |
| Sep 30, 2018 | 0.00% |
| Jun 30, 2018 | -0.27% |
| Mar 31, 2018 | -0.05% |
| Dec 31, 2017 | 0.01% |
| Sep 30, 2017 | -0.06% |
| Jun 30, 2017 | -0.02% |
| Mar 31, 2017 | -0.02% |